These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 26558423)

  • 1. De Novo MYC and BCL2 Double-hit B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) in Pediatric and Young Adult Patients Associated With Poor Prognosis.
    Liu W; Hu S; Konopleva M; Khoury JD; Kalhor N; Tang G; Bueso-Ramos CE; Jorgensen JL; Lin P; Medeiros LJ; Lu X
    Pediatr Hematol Oncol; 2015; 32(8):535-47. PubMed ID: 26558423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunophenotypic and cytogenetic findings of B-lymphoblastic leukemia/lymphoma associated with combined IGH/BCL2 and MYC rearrangement.
    Kelemen K; Holden J; Johnson LJ; Davion S; Robetorye RS
    Cytometry B Clin Cytom; 2017 Jul; 92(4):310-314. PubMed ID: 26517296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nationwide study of pediatric B-cell precursor acute lymphoblastic leukemia with chromosome 8q24/MYC rearrangement in Japan.
    Sakaguchi K; Imamura T; Ishimaru S; Imai C; Shimonodan H; Fujita N; Okada K; Taketani T; Kanai R; Tauchi H; Kato M; Kojima Y; Watanabe A; Deguchi T; Hashii Y; Kiyokawa N; Taki T; Saito AM; Horibe K; Manabe A; Sato A; Koh K
    Pediatr Blood Cancer; 2020 Jul; 67(7):e28341. PubMed ID: 32323914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphomas with pseudo-double-hit BCL6-MYC translocations due to t(3;8)(q27;q24) are associated with a germinal center immunophenotype, extranodal involvement, and frequent BCL2 translocations.
    Johnson SM; Umakanthan JM; Yuan J; Fedoriw Y; Bociek RG; Kaiser-Rogers K; Sanmann JN; Montgomery ND
    Hum Pathol; 2018 Oct; 80():192-200. PubMed ID: 29902576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome.
    Li S; Lin P; Fayad LE; Lennon PA; Miranda RN; Yin CC; Lin E; Medeiros LJ
    Mod Pathol; 2012 Jan; 25(1):145-56. PubMed ID: 22002575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations].
    Luo DL; Liu YH; Zhang F; Xu FP; Yan LX; Chen J; Xu J; Luo XL; Zhuang HG
    Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):584-8. PubMed ID: 24314242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and genetic characterization of de novo double-hit B cell precursor leukemia/lymphoma.
    Stratmann JA; von Rose AB; Koschade S; Wendelin K; Köhler F; Heinsch M; Schiller K; Haferlach C; Wattad M; Rieder H; Serve H; Gökbuget N; Steffen B
    Ann Hematol; 2019 Mar; 98(3):647-656. PubMed ID: 30613837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-hit pancreatic B-lymphoblastic lymphoma with a variant translocation t(2;18)(p11;q21).
    Yamamoto K; Kawamoto S; Kitao A; Mizutani Y; Inui Y; Yakushijin K; Kajimoto K; Hayashi Y; Matsuoka H; Minami H
    Int J Hematol; 2019 Jul; 110(1):107-114. PubMed ID: 30963474
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Soliman DS; Al-Sabbagh A; Ibrahim F; Fareed S; Talaat M; Yassin MA
    J Hematol; 2017 Sep; 6(2-3):62-67. PubMed ID: 32300395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple-hit B-cell Lymphoma With MYC, BCL2, and BCL6 Translocations/Rearrangements: Clinicopathologic Features of 11 Cases.
    Wang W; Hu S; Lu X; Young KH; Medeiros LJ
    Am J Surg Pathol; 2015 Aug; 39(8):1132-9. PubMed ID: 25828391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A leukemic double-hit follicular lymphoma associated with a complex variant translocation, t(8;14;18)(q24;q32;q21), involving BCL2, MYC, and IGH.
    Minakata D; Sato K; Ikeda T; Toda Y; Ito S; Mashima K; Umino K; Nakano H; Yamasaki R; Morita K; Kawasaki Y; Sugimoto M; Yamamoto C; Ashizawa M; Hatano K; Oh I; Fujiwara SI; Ohmine K; Kawata H; Muroi K; Miura I; Kanda Y
    Cancer Genet; 2018 Jan; 220():44-48. PubMed ID: 29310838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma.
    Ye Q; Xu-Monette ZY; Tzankov A; Deng L; Wang X; Manyam GC; Visco C; Montes-Moreno S; Zhang L; Dybkær K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Parsons BM; Møller MB; Piris MA; Winter JN; Medeiros LJ; Hu S; Young KH
    Oncotarget; 2016 Jan; 7(3):2401-16. PubMed ID: 26573234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
    Green TM; Young KH; Visco C; Xu-Monette ZY; Orazi A; Go RS; Nielsen O; Gadeberg OV; Mourits-Andersen T; Frederiksen M; Pedersen LM; Møller MB
    J Clin Oncol; 2012 Oct; 30(28):3460-7. PubMed ID: 22665537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of history of follicular lymphoma, induction regimen and stem cell transplant in patients with MYC/BCL2 double hit lymphoma.
    Li S; Saksena A; Desai P; Xu J; Zuo Z; Lin P; Tang G; Yin CC; Seegmiller A; Jorgensen JL; Miranda RN; Reddy NM; Bueso-Ramos C; Medeiros LJ
    Oncotarget; 2016 Jun; 7(25):38122-38132. PubMed ID: 27203548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo B lymphoblastic leukemia/lymphoma in an adult with t(14;18)(q32;q21) and c-MYC gene rearrangement involving 10p13.
    Subramaniyam S; Fraser CR; Rao PH; Feldman E; Ely S; Mathew S
    Leuk Lymphoma; 2011 Nov; 52(11):2195-9. PubMed ID: 21718139
    [No Abstract]   [Full Text] [Related]  

  • 16. [Successful treatment with dose-adjusted EPOCH-R for triple-hit lymphoma having BCL2, BCL6 and MYC translocations].
    Hashimoto A; Fujimi A; Kanisawa Y; Nakajima C; Hayasaka N; Yamada S; Okuda T; Minami S; Matsumoto T; Shibata T; Hamaguchi K; Kamihara Y; Iwasaki S; Kato J
    Rinsho Ketsueki; 2015 Jul; 56(7):905-10. PubMed ID: 26256929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unexpected favorable outcome in a patient with high grade B-cell lymphoma with abnormalities of MYC, BCL6 and BCL2 loci.
    Adams T; Fuchs D; Shadoan PK; Johnstone L; Lau BM; McGhan L; Anwer F; Al-Kateb H
    Cancer Genet; 2018 Apr; 222-223():25-31. PubMed ID: 29666005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-hit lymphomas: clinical, morphological, immunohistochemical and cytogenetic study in a series of Brazilian patients with high-grade non-Hodgkin lymphoma.
    Oliveira CC; Maciel-Guerra H; Kucko L; Hirama EJ; Brilhante AD; Quevedo FC; da Cunha IW; Soares FA; Niero-Melo L; Dos Reis PP; Domingues MA
    Diagn Pathol; 2017 Jan; 12(1):3. PubMed ID: 28061782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precursor B-Cell Acute Lymphoblastic Leukemia With MYC and BCL2 Rearrangements Presenting as Extensive Extranodal Disease in an Adolescent.
    Oberoi S; Dawson A; Marko D; Almiski M; Higgins R; Israels SJ
    J Pediatr Hematol Oncol; 2021 May; 43(4):e501-e504. PubMed ID: 33448716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYC cytogenetic status correlates with expression and has prognostic significance in patients with MYC/BCL2 protein double-positive diffuse large B-cell lymphoma.
    Wang XJ; Medeiros LJ; Lin P; Yin CC; Hu S; Thompson MA; Li S
    Am J Surg Pathol; 2015 Sep; 39(9):1250-8. PubMed ID: 25828389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.